ORAL ALLERGY TREATMENTS: Rx | ||||
---|---|---|---|---|
Generic | Brand | Strength | Form | Dose |
ALLERGEN EXTRACT | ||||
short ragweed pollen allergen extract (Ambrosia artemisiifolia) | Ragwitek | 12 Amb a 1‑U | sub– lingual tabs |
Children: <18yrs: not established. Adults: Initiate ≥12wks before onset of ragweed pollen season and continue throughout season. Give 1st dose under physician supervision; observe ≥30mins for severe allergic reaction; if tolerated, subsequent doses may be taken at home. 18–65yrs: 1 tab daily. |
timothy grass pollen allergen extract | Grastek | 2800 BAUs | sub– lingual tabs |
Adults and Children: <5yrs: not established. Initiate at least 12wks before onset of grass pollen season and continue throughout season. Give 1st dose under physician supervision; observe ≥30mins for signs/symptoms of a severe allergic reaction; if tolerated, subsequent doses may be taken at home. ≥5−65yrs: one tab daily. |
ANTIHISTAMINE (FIRST GENERATION H1 ANTAGONIST) |
||||
carbinoxamine maleate | — | 4mg | scored tabs | Children: <2yrs: Contraindicated. 2−5yrs: 0.2−0.4mg/kg/day in 3−4 divided doses. 6−11yrs: 2−4mg 3−4 times daily. Adults: 4−8mg orally 3−4 times daily. |
4mg/ 5mL |
soln | |||
Karbinal ER | 4mg/ 5mL |
ext-rel oral susp | Children: <2yrs: Contraindicated. 2−3yrs: 3.75−5mL (3−4mg) every 12hrs; 4−5yrs: 3.75−10mL (3−8mg) every 12hrs; 6−11yrs: 7.5−15mL (6−12mg) every 12hrs. Adults: 7.5−20mL (6−16mg) every 12hrs. |
|
cyprohepta– dine HCl |
— | 4mg | scored tabs | Children: <2yrs: not recommended. 2−6yrs: 2mg 2−3 times per day; max 12mg daily. 7−14yrs: 4mg 2−3 times per day; max 16mg daily. Adults: ≥14yrs: Initially 4mg 3 times daily; usual range 12−16mg/day; max 0.5mg/kg per day. |
hydroxyzine HCl | — | 10mg, 25mg, 50mg | tabs | Children: <6yrs: 50mg daily. ≥6yrs: 50−100mg daily. Both in divided doses. Adults: 25mg 3−4 times daily. |
10mg/ 5mL |
syrup† | |||
hydroxyzine pamoate | Vistaril | 25mg, 50mg | caps | Children: <6yrs: 50mg daily. ≥6yrs: 50−100mg daily. Both in divided doses. Adults: 25mg 3−4 times daily. |
ANTIHISTAMINE (SECOND GENERATION H1 ANTAGONIST) |
||||
desloratadine | — | 2.5mg, 5mg | ODT* | Adults and Children: Dissolve on tongue; swallow with or without water. <6yrs: use other forms. 6−11yrs: 2.5mg once daily. ≥12yrs: 5mg once daily. Renal or hepatic impairment: Initially 5mg every other day. |
Clarinex | 5mg | tabs | Children: Use other forms. Adults: 5mg once daily. Renal or hepatic impairment: Initially 5mg every other day. |
|
0.5mg/ mL |
syrup | Adults and Children: <6mos: not recommended. 6−11mos: 1mg (2mL). 1−5yrs: 1.25mg (2.5mL). 6−11yrs: 2.5mg (5mL). ≥12yrs: 5mg (10mL). All: Once daily. |
||
LEUKOTRIENE RECEPTOR ANTAGONIST | ||||
montelukast (as sodium) | Singulair | 10mg | tabs | Adults and Children: Take granules by mouth within 15min of opening packet; may dissolve in 5mL of cold or room temperature baby formula or breast milk, or mix in spoonful of soft applesauce, carrots, rice, or ice cream. <6mos w/perennial allergic rhinitis or <2yrs w/seasonal allergic rhinitis: not established. 6−23mos: one 4mg granule packet. 2−5yrs: One 4mg chew tab or granule packet. 6−14yrs: One 5mg chew tab. ≥15yrs: One 10mg tab. For all: Take once daily. |
4mg, 5mg | chew tabs* | |||
4mg/ packet |
oral gran– ules |
|||
ANTIHISTAMINE + SYMPATHOMIMETIC | ||||
acrivastine/ pseudoephe– drine HCl |
Semprex-D | 8mg/ 60mg |
caps | Children: Not established. Adults: 1 cap every 4−6hrs, max 4 caps/day. |
desloratadine/ pseudoephe– drine sulfate |
Clarinex-D 12 Hour | 2.5mg/ 120mg |
ext-rel tabs | Children: Not recommended. Adults: Swallow whole. 1 tab every 12hrs. |
Clarinex-D 24 Hour | 5mg/ 240mg |
ext-rel tabs | Children: Not recommended. Adults: Swallow whole. 1 tab once daily. |
|
NOTES | ||||
Key: ODT = orally disintegrating tablets; soln = solution; * = contains phenylalanine; † = contains alcohol. Not an inclusive list of medications and/or official indications. Please see drug monograph at www.eMPR.com and/or contact company for full drug labeling. (Rev. 10/2019) |
Please login or register first to view this content.